SEC Form 3 · accession 0000899243-15-002851
Global Blood Therapeutics, Inc. · GBT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Willie L. Brown Jr.
Director
Period of report
Aug 11, 2015
Accepted (ET)
Aug 11, 2015 · 5:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001629137
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 21,428 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares of Common Stock are subject to the Issuer's right or repurchase, which lapses at a rate of 25% on January 1, 2016 and in 12 equal quarterly installments thereafter.
Remarks
Exhibit List: Exhibit 24.1 - Power of Attorney